FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313704509> ?p ?o ?g. }

• W4313704509 endingPage "56" @default.
• W4313704509 startingPage "46" @default.
• W4313704509 abstract "Abstract Glucose 6-phosphate isomerase (G6PI) is an indicator to assist in diagnosis of rheumatoid arthritis (RA) and monitor the disease. It also plays a key role in proliferating RA synovial tissues, pannus formation, and invasion and destruction of articular cartilage. In this study, we synthesized nanoparticles targeting G6PI (siG6PI-MSN) using mesoporous silica nanocarriers (MSN) and small interfering RNA (siRNA), followed by identifying the characteristics and functions, and preliminarily exploring their application in the treatment of RA in vivo with a type II collagen-induced arthritis (CIA) rat model. It showed that the synthetic functionalized carrier had a regular pore structure and a specific volume and surface area. No obvious hemolysis or toxicity of the carrier was found when its concentration was below 100 µg/ml. Cytological results in vitro suggested that siG6PI-MSN significantly inhibited G6PI expression and reduced the ability of proliferation, migration, and invasion of FLSs, compared with the siNC-MSN group. In vivo results in the CIA rat model showed that the arthritis index and degree of joint swelling among rats in the siG6PI-MSN-treatment group were significantly lower than those in the control group. Moreover, the number of FLSs in Synovium and the levels of TNF α and IL-1 β were also significantly decreased in the siG6PI-MSN group. Histopathology of the synovial tissue and cartilage revealed siG6PI-MSN treatment significantly reduced the pathological manifestations of arthritis. In conclusion, siG6PI-MSN effectively suppresses the proliferation and invasive growth of synovial tissue and improve joint swelling and inflammatory infiltration, thereby preventing joint damage in RA. This carrier may be a new therapeutic measure for RA, with potential social and economic benefits." @default.
• W4313704509 created "2023-01-08" @default.
• W4313704509 creator A5015212617 @default.
• W4313704509 creator A5016498097 @default.
• W4313704509 creator A5028428278 @default.
• W4313704509 creator A5032361814 @default.
• W4313704509 creator A5034633035 @default.
• W4313704509 creator A5037797754 @default.
• W4313704509 creator A5053007944 @default.
• W4313704509 creator A5063996707 @default.
• W4313704509 date "2023-01-01" @default.
• W4313704509 modified "2023-10-16" @default.
• W4313704509 title "Preparation of mesoporous silica nanocarriers targeting glucose-6-phosphate isomerase inhibition and application in the treatment of rheumatoid arthritis" @default.
• W4313704509 cites W1207820822 @default.
• W4313704509 cites W1804398254 @default.
• W4313704509 cites W1910056502 @default.
• W4313704509 cites W1980264776 @default.
• W4313704509 cites W1991022986 @default.
• W4313704509 cites W2049628668 @default.
• W4313704509 cites W2058559717 @default.
• W4313704509 cites W2077487036 @default.
• W4313704509 cites W2135647402 @default.
• W4313704509 cites W2569892382 @default.
• W4313704509 cites W2609239832 @default.
• W4313704509 cites W2617903725 @default.
• W4313704509 cites W2623617647 @default.
• W4313704509 cites W2793538920 @default.
• W4313704509 cites W2795125879 @default.
• W4313704509 cites W2885814196 @default.
• W4313704509 cites W2910346583 @default.
• W4313704509 cites W2943326887 @default.
• W4313704509 cites W2962775539 @default.
• W4313704509 cites W2964931508 @default.
• W4313704509 cites W2990182705 @default.
• W4313704509 cites W2999345249 @default.
• W4313704509 cites W3012175342 @default.
• W4313704509 cites W3084513853 @default.
• W4313704509 cites W3119892992 @default.
• W4313704509 cites W3130986863 @default.
• W4313704509 cites W3132469711 @default.
• W4313704509 cites W3191894985 @default.
• W4313704509 cites W3198304517 @default.
• W4313704509 cites W4210968471 @default.
• W4313704509 cites W4233867310 @default.
• W4313704509 doi "https://doi.org/10.1093/cei/uxac116" @default.
• W4313704509 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36610698" @default.
• W4313704509 hasPublicationYear "2023" @default.
• W4313704509 type Work @default.
• W4313704509 citedByCount "0" @default.
• W4313704509 crossrefType "journal-article" @default.
• W4313704509 hasAuthorship W4313704509A5015212617 @default.
• W4313704509 hasAuthorship W4313704509A5016498097 @default.
• W4313704509 hasAuthorship W4313704509A5028428278 @default.
• W4313704509 hasAuthorship W4313704509A5032361814 @default.
• W4313704509 hasAuthorship W4313704509A5034633035 @default.
• W4313704509 hasAuthorship W4313704509A5037797754 @default.
• W4313704509 hasAuthorship W4313704509A5053007944 @default.
• W4313704509 hasAuthorship W4313704509A5063996707 @default.
• W4313704509 hasConcept C105702510 @default.
• W4313704509 hasConcept C150903083 @default.
• W4313704509 hasConcept C161790260 @default.
• W4313704509 hasConcept C18150654 @default.
• W4313704509 hasConcept C185592680 @default.
• W4313704509 hasConcept C203014093 @default.
• W4313704509 hasConcept C207001950 @default.
• W4313704509 hasConcept C2776914184 @default.
• W4313704509 hasConcept C2777077863 @default.
• W4313704509 hasConcept C2777496208 @default.
• W4313704509 hasConcept C2777575956 @default.
• W4313704509 hasConcept C2780035454 @default.
• W4313704509 hasConcept C2780550940 @default.
• W4313704509 hasConcept C55493867 @default.
• W4313704509 hasConcept C71924100 @default.
• W4313704509 hasConcept C82776694 @default.
• W4313704509 hasConcept C86803240 @default.
• W4313704509 hasConcept C98274493 @default.
• W4313704509 hasConceptScore W4313704509C105702510 @default.
• W4313704509 hasConceptScore W4313704509C150903083 @default.
• W4313704509 hasConceptScore W4313704509C161790260 @default.
• W4313704509 hasConceptScore W4313704509C18150654 @default.
• W4313704509 hasConceptScore W4313704509C185592680 @default.
• W4313704509 hasConceptScore W4313704509C203014093 @default.
• W4313704509 hasConceptScore W4313704509C207001950 @default.
• W4313704509 hasConceptScore W4313704509C2776914184 @default.
• W4313704509 hasConceptScore W4313704509C2777077863 @default.
• W4313704509 hasConceptScore W4313704509C2777496208 @default.
• W4313704509 hasConceptScore W4313704509C2777575956 @default.
• W4313704509 hasConceptScore W4313704509C2780035454 @default.
• W4313704509 hasConceptScore W4313704509C2780550940 @default.
• W4313704509 hasConceptScore W4313704509C55493867 @default.
• W4313704509 hasConceptScore W4313704509C71924100 @default.
• W4313704509 hasConceptScore W4313704509C82776694 @default.
• W4313704509 hasConceptScore W4313704509C86803240 @default.
• W4313704509 hasConceptScore W4313704509C98274493 @default.
• W4313704509 hasFunder F4320321001 @default.
• W4313704509 hasIssue "1" @default.
• W4313704509 hasLocation W43137045091 @default.
• W4313704509 hasLocation W43137045092 @default.

• next